Drug Information Center

College of Pharmacy

Frequently Asked Questions

September 01, 2008

September 2008 FAQs

Why is fondaparinux contraindicated in low body weight surgery patients but not in other low weight patients?

Which patients should be given antibiotics to prevent infective endocarditis? Summary of the ACC/AHA 2008 guidelines

What is the role of recombinant activated Factor VII in intracranial hemorrhage?

The influence of nonadherence to antiepileptic drugs (AEDs) on mortality in epilepsy

August 2008 FAQs

Is bivalirudin an option for treating heparin-induced thrombocytopenia in patients not undergoing a percutaneous coronary intervention?

How can the potential for abacavir hypersensitivity reactions be minimized?

July 2008 FAQs

Diabetes control and macrovascular complications

Antipsychotics and risk in patients with dementia

Preoperative statins and effects on mortality

Low-molecular weight heparin for the treatment of thromboembolism in obese patients

June 2008 FAQs

Clinical controversy: The MENDS trial (maximizing efficacy of targeted sedation and reducing neurological dysfunction)

Cardiovascular Disease and Homocysteine

Pharmacist's role in the management of heart failure patients

May 2008 FAQs

Medication errors in US children’s hospitals

Is there a drug-drug interaction between clopidogrel and omeprazole?

Prasugrel: a thienopyridine drug on the horizon

Resistant hypertension: summary of the American Heart Association’s scientific statement

April 2008 FAQs

Intensive glycemic control may be detrimental for patients with type 2 diabetes: results of the ACCORD trial

A review of the update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

ENHANCE trial: is there a role for ezetimibe in managing dyslipidemia?

What is the role of vasopressin in septic shock?

March 2008 FAQs

What anticoagulants can be given to a patient with heparin-induced thrombocytopenia during dialysis sessions?

Occupational exposure to hazardous drugs—recommendations for oral dosage forms

Warnings regarding sedative-hypnotic medications: an update

Tuberculosis in human immunodeficiency virus (HIV) patients: managing drug interactions

February 2008 FAQs

What are the new changes in USP 797 for 2008?

Are antipsychotics an appropriate treatment for aggressive challenging behavior in patients with an intellectual disability?

Haloperidol and cardiovascular concerns Recent News

The use of intralipid emulsion for the reversal of local anesthetic toxicity

January 2008 FAQs

New asthma guidelines

Hearing loss and PDE5 inhibitors

Haemophilus type b (Hib) vaccine shortage

Potential interaction between warfarin and cranberry juice: updated data


FAQs Archives 2007

FAQs Archives 2006

FAQs Archives 2003


< Go Back